FOREJTOVA, S., H. MANN, J. STOLFA, K. VEDRAL, I. FENCLOVA, Danka NÉMETHOVÁ and K. PAVELKA. Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic. Clinical Rheumatology. New York: Springer, 2008, vol. 27, No 8, p. 1005-1013. ISSN 0770-3198.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic
Name in Czech Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic
Authors FOREJTOVA, S. (203 Czech Republic), H. MANN (203 Czech Republic), J. STOLFA (203 Czech Republic), K. VEDRAL (203 Czech Republic), I. FENCLOVA (203 Czech Republic), Danka NÉMETHOVÁ (703 Slovakia, guarantor) and K. PAVELKA (203 Czech Republic).
Edition Clinical Rheumatology, New York, Springer, 2008, 0770-3198.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.559
RIV identification code RIV/00216224:14310/08:00033761
Organization unit Faculty of Science
UT WoS 000257370000009
Keywords in English Ankylosing spondylitis; BASDAI; Disability; HAQ-DI; Health status; Questionnaire
Tags Ankylosing spondylitis, BASDAI, disability, HAQ-DI, health status, questionnaire
Tags International impact, Reviewed
Changed by Changed by: RNDr. Danka Haruštiaková, Ph.D., učo 163612. Changed: 28/6/2009 21:58.
Abstract
The aim of the study was to evaluate factors that influence health status and work disability in patients with ankylosing spondylitis (AS) in the Czech Republic. Data were collected in a retrospective fashion directly from patients with AS using mailed questionnaires containing questions regarding sociodemographic characteristics of patients, the course of their disease, therapy, rehabilitation, quality of life, and ability to work. HAQ-DI (Health Assessment Questionnaire-Disability Index) and BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) were also included in the questionnaires; 1,008 questionnaires were suitable for further statistical analysis. The average age of patients was 50.2 years, the average symptom duration was 23.0 years. Mean time from first symptoms to diagnosis was 9.1 years. Receiving disability pension was more frequent among men (64%) compared to women (56%) (P=0.012), despite the fact that women had higher BASDAI (P<0.001) and HAQ-DI (P=0.004) scores. Fifty eight percent of patients reported a BASDAI score more than 4 (current cutoff value for initiation of biological therapy), but only 1% of patients were treated by anti TNF alpha agents within the last year.
Abstract (in Czech)
The aim of the study was to evaluate factors that influence health status and work disability in patients with ankylosing spondylitis (AS) in the Czech Republic. Data were collected in a retrospective fashion directly from patients with AS using mailed questionnaires containing questions regarding sociodemographic characteristics of patients, the course of their disease, therapy, rehabilitation, quality of life, and ability to work. HAQ-DI (Health Assessment Questionnaire-Disability Index) and BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) were also included in the questionnaires; 1,008 questionnaires were suitable for further statistical analysis. The average age of patients was 50.2 years, the average symptom duration was 23.0 years. Mean time from first symptoms to diagnosis was 9.1 years. Receiving disability pension was more frequent among men (64%) compared to women (56%) (P=0.012), despite the fact that women had higher BASDAI (P<0.001) and HAQ-DI (P=0.004) scores. Fifty eight percent of patients reported a BASDAI score more than 4 (current cutoff value for initiation of biological therapy), but only 1% of patients were treated by anti TNF alpha agents within the last year.
Links
MSM0021622412, plan (intention)Name: Interakce mezi chemickými látkami, prostředím a biologickými systémy a jejich důsledky na globální, regionální a lokální úrovni (INCHEMBIOL) (Acronym: INCHEMBIOL)
Investor: Ministry of Education, Youth and Sports of the CR, Interactions among the chemicals, environment and biological systems and their consequences on the global, regional and local scales (INCHEMBIOL)
PrintDisplayed: 30/5/2024 02:47